Materials and Methods
Peptide Synthesis All peptides, including those with appropriate iso/epi modifications, were synthesized following an accelerated FMOC-protected solid-phase peptide synthesis protocol. 1 Isomerized peptides were synthesized by incorporating the appropriate isomeric form of the amino acid residue during synthesis. Fluorophores Edans and Dabcyl were purchased as FMOC-protected amino acid conjugates and attached to peptides during synthesis. Following synthesis, peptides were purified on a Varian ProStar HPLC using a Phenomenex Jupiter Proteo C12 4 μm 90 Å 250 mm × 4.6 mm column and then validated by LC/MS. Purified peptides were stored frozen in 50/50 acetonitrile/water (v/v) and vacuum-dried before reconstitution in appropriate buffers.
In Vitro Aging
Lyophilized amyloid beta powder was disentangled via ammonium hydroxide treatment. 2 Following disentanglement, aliquots containing 100 μg amyloid beta were lyophilized before reconstitution in 1 mL 50 mM Tris 7.4 pH at 37 °C. Samples were aged in microcentrifuge tubes in a sand-bath style incubator. Aliquots were removed at given timepoints and frozen until analysis. Aged samples were digested at room temperature for 18 h with chymotrypsin in 200 mM Tris buffer with 4 mM CaCl2 and an enzyme:substrate weight ratio of 1:2 to ensure complete digestion of fibrils. Digested samples were frozen until analysis.
LC-MS Analysis
Samples were analyzed on an Agilent 1100 HPLC or a Thermo Fisher Easy nLC II interfaced with a Thermo Fisher LTQ or Thermo Fisher Velos Pro Orbitrap using electrospray ionization sources. For the Agilent 1100, peptides were separated on a Thermo Scientific BetaBasic C-18 3 μm, 150 x 2.1 mm column using water with 0.1% formic acid for mobile phase A, and methanol with 0.1% formic acid for mobile phase B. The Easy nLC II was operated with a capillary column packed in-house to a length of ~10 cm with Waters Acuity CSH C18 1.7 μm resin using a Shotgun Proteomics Inc high pressure vessel. For the Easy nLC II, mobile phase A was water with 0.1% formic acid, and mobile phase B was acetonitrile with 0.1% formic acid.
In Vitro Fluorimetry
Aliquots containing 75 μg of purified peptide were added to a 96-well plate in 50 mM acetate buffer pH 5.5 with 1 mM EDTA and 1 mM DTT to prevent active site oxidation. Cathepsin L was added at an enzyme:substrate ratio of 1:150. Digestion was then monitored using a Biotek Synergy H1 fluorescent plate reader with an excitation wavelength of 336 nm and emission wavelength of 490 nm. Fluorescence is plotted as the average of 3 runs and error bars represent the standard deviation.
The presence of amyloid fibrils was examined by ThT assay. 3 Peptides were diluted to 2 μM in
Tris buffer before addition of 30 μM ThT. Emission scans were performed on a QuantaMaster-400 fluorimeter, using an excitation wavelength of 440 nm.
In Vitro Digestion
Aliquots containing 75 μg of purified peptide were dissolved in 150 μL of buffer. Following imaging, cells were counted in FIJI, 4 using a threshold image approach that was validated manually. Raw fluorescence data was recorded for both peptide isomers in addition to a negative control (i.e. cells without peptide). To eliminate background noise, scattering, and autofluorescence, only fluorescent signal that is above the negative control was used for quantitation. For cells with lysosomal labels, Invitrogen Lysotracker Red DND-99 was used in accordance with the manufacturer's instructions. Lysotracker was excited at 561 nm and emission was recorded from 580-735 nm.
Cell Fixing and Immunohistochemistry (IHC)
At fixation timepoints, cells were briefly washed with cold PBS. Cells were then fixed in 4%
paraformaldehyde for 30 minutes at room temperature. After fixation, paraformaldehyde was removed and replaced with PBS. Fixed microglia were stained for ED-1 (CD86) with a secondary antibody conjugated to AlexaFluor 488 to aid in visualization. Alexafluor was excited at 488 nm and emission was recorded from 499-562 nm. Slides were kept at 4°C until viewing using the Zeiss 880 equipped with a Plan-Apochromat 63x/1.4 Oil DIC M27 objective.
Molecular Modeling
The active site of cathepsin L was modeled in Maestro 11 (Schrödinger, LLC). The PDB deposit, 3K24, was processed to include H-bonds and displayed using the surface representation. The QLA peptide bound in the crystal structure was modified to QLD and evaluated for potential H-bonds as well as steric clashes. The chirality of the alpha-carbon of the Asp residue was inverted to generate the D-Asp isomer.
Safety Statement
No unexpected or unusually high safety hazards were encountered. Note: the synthetic amyloid beta 1-9 peptide yields sufficient chromatographic separation to quantitate the isomerization rate at both Asp 1 and Asp 7 simultaneously (as shown in Fig. S4) . Conversely, the full-length amyloid beta 1-40 and 1-42 proteins require digestion prior to isomer analysis via LC-MS. To quantitate the isomerization rate at Asp 1 and Asp 7, the full-length amyloid protein was aged intact, and then digested with chymotrypsin immediately before analysis. Quantitation is achieved by analyzing the relative peak area of the chymotryptic peptide products, 
